MSNBC Andrea Mitchell Reports June 4, 2024 16:20:00
World and it's only growing in terms of numbers of cases and the burden of disease. there aren't good treatments and people are desperate, people want hope. on the other hand, if it doesn't really work and if it doesn't provide benefit, that's empty hope and this is the drug that, you know, doesn't have the kind of evidence to prove effectiveness that is normally accompanying fda decisions. it's an expensive drug that will require monthly infusions and it -- and it comes with some safety risks in terms of brain swelling and bleeding. so it's a complex risk benefit analysis. it is going to be v...